Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Wednesday 12 August, 2020

Goldman Sachs & Co.

Form 38.5(b) - Willis Towers Watson PLC- Amendment

RNS Number : 8931V
Goldman Sachs & Co. LLC
12 August 2020
 

Amendment - due to the amendment of Derivative transactions, the disclosure made on 06 August for dealings on 05 August has been updated. Sections 2(a), 3(b) and Supplemental have been updated.

 

FORM 38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

1. KEY INFORMATION

 

Name of exempt principal trader

GOLDMAN SACHS & CO. LLC

Company dealt in

WILLIS TOWERS WATSON PLC

Class of relevant security to which the dealings being disclosed relate (Note1)

USD 0.000304635 ordinary shares

Date of dealing

05 August 2020

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in  (Note 2)

 

 

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

272,053.088

(0.21)

92,410.088

(0.07)

(2) Derivatives (other than options)

51,018

(0.03)

124,990

(0.09)

(3) Options and agreements to purchase/sell

0

(0.00)

0

(0.00)

Total

323,071.088

(0.24)

217,273.088

(0.16)

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in  (Note 2)

 

Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

 

 

 

 

(2) Derivatives (other than options)

 

 

 

 

(3) Options and agreements to purchase/sell

 

 

 

 

Total

 

 

 

 

 

3.  DEALINGS (Note 3)

(a) Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit  (Note 4)

Purchase

44

202.5200 USD

Purchase

469

202.5200 USD

Purchase

12

202.5200 USD

Purchase

80

202.5200 USD

Purchase

23

202.5200 USD

Sale

1,362

202.5200 USD

Sale

94

202.5200 USD

Sale

321

202.5200 USD

Sale (Loan Adjust)

34

N/A

 

(b) Derivatives transactions (other than options transactions)

 

Product name, e.g. CFD

Nature of transaction  (Note 5)

Number of relevant securities  (Note 6)

Price per unit  (Note 4)

SWAP

Reducing a long position

45

202.5200 USD

 

(c) Options transactions in respect of existing relevant securities

 

(i) Writing, selling, purchasing or varying

 

Product name,e.g. call option

Writing, selling,  purchasing, varying etc.

Number of securities to which the option relates  (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit  (Note 4)

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Product name,e.g. call option

Number of securities

Exercise price per unit  (Note 4)

 

 

 

 

(d)  Other dealings (including transactions in respect of new securities)  (Note 3)

 

Nature of transaction  (Note 7)

Details

Price per unit (if applicable)  (Note 4)

 

 

 

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.  If none, this should be stated. 

NONE

 

Is a Supplemental Form 8 attached? (Note 9)  YES

 

Date of disclosure

12 August 2020

Contact name

Kashif Rafiq and Papa Lette

Telephone number

+44(20) 7051 0547 / +44(20) 7774 7442

Name of offeree/offeror with which connected

WILLIS TOWERS WATSON PLC

Nature of connection (Note 9)

Advisor to Offeree

 

SUPPLEMENTAL FORM 38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DETAILS OF OPEN POSITIONS

 

OPEN POSITIONS (Note 1)

 

Product name,e.g. call option

Written or purchased

Number of relevant securities to which the option or derivative relates

Exercise price (Note 2)

Type, e.g. American, European etc.

Expiry date

Swap

Purchased

103

0.0000

N/A

23/09/2020

Swap

Sold

185

0.0000

N/A

23/09/2020

Swap

Sold

14,499

0.0000

N/A

14/04/2021

Swap

Sold

31,590

0.0000

N/A

14/04/2021

 

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rules 8 and 38.5 of the Rules. If in doubt, consult the Panel.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEEASPAFSPEEEA

a d v e r t i s e m e n t